Navigation Links
New Study Provides Benchmarks for Optimizing Marketing Staff Levels to Drive Growth
Date:2/5/2009

CHAPEL HILL, N.C., Feb. 5 /PRNewswire/ -- In today's tough economy, maintaining operational efficiencies remains key, even while focusing on strategy and tactics to drive growth and profitability. In an effort to better understand the resources dedicated by biopharmaceutical companies to support marketing operations, a recent benchmark study was conducted by Best Practices, LLC, with insights available in the newly published report, "Benchmarks for Optimizing Marketing Staff Levels to Drive Growth." Data from this study were collected from more than sixty biopharma marketing leaders.

Benchmark data shares insights from a number of critical areas, including:

-- Staffing and productivity levels utilized across healthcare business models

    -- Growth and profit margin levels across biopharma portfolios
    -- Strategic and tactical activities that drive profitability & growth

The metrics shared in this study, segmented across pharma/biotech, medical devices and generic products, were gathered from across the biopharma industry including such companies as Abbott, Amgen, Baxter, Johnson & Johnson, Novartis, Pfizer, Roche, and Sanofi-Aventis.

    Key metrics found in the report include:
    -- Number of Products Supported Per Tactical Marketing FTE
    -- Number of Strategic Marketing FTEs per $100 Million
    -- Time & Activity Benchmarks for Strategic Marketing Staff
    -- Strategic Marketing Staff Benchmarks Across Key Activities
    -- Tactical Marketing Staff Benchmarks Across Key Activities

For more information on this report, contact Ben Gregory at bgregory@best-in-class.com or (919) 767-9160. To access the full report or download a complimentary copy of the report summary, go to www.best-in-class.com/rr977.htm.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. For more than 15 years, our highly credentialed research staff has conducted primary research exclusively for our Fortune 500 client base.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Peregrine Pharmaceuticals Bavituximab Achieves Primary Endpoint in First Stage of Phase II Lung Cancer Study
2. Results From Phase 2 Clinical Study of 6R-BH4 in Peripheral Arterial Disease Not Statistically Significant
3. New Study Provides Benchmarks for Winning Brand Team Management
4. New Study Shares Insights for Competitive Intelligence Policies, Ethics and Data Collection
5. New Multi-Center Study Finds Masimo SET Pulse Oximetry Screening Significantly Improves Detection of Congenital Heart Disease in Newborns
6. Epilepsia Study Demonstrates New Add-on Antiepileptic Drug Vimpat(R) (lacosamide) Significantly Reduces Partial-Onset Seizures in Adults With Epilepsy
7. Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing
8. Clinical Research Study Focuses on Little Known Behavioral Changes Related to Parkinsons Disease
9. Cardiovascular Side Effects of Pioglitazone and Rosiglitazone Linked to Vascular and Energy Pathways by Genomas Clinical Study
10. Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay
11. Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2017)... PA (PRWEB) , ... June 22, 2017 , ... ... and superior results to clients throughout the biopharma and life sciences industries, continue ... the industry is seeing. Tunnell’s Kip Wolf will be speaking on “The State ...
(Date:6/20/2017)... ... 20, 2017 , ... CTNext , Connecticut’s go-to resource ... a Higher Education Entrepreneurship Advisory Committee to implement the recommendations of the master ... representatives from 35 higher education institutions across the state over the past six ...
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... ... Linda Robbie, PhD, a well-versed leader with extensive assay development and biomarker expertise, ... Cambridge Biomedical is a Boston CRO specializing in bio-analytical assay development and sample ...
(Date:6/19/2017)... ... June 19, 2017 , ... EDETEK, ... reported today that it is launching two new additions of its award-winning cloud-based ... new capabilities at the DIA 2017 Annual Meeting in Chicago, IL, June 19-22, ...
Breaking Biology Technology:
(Date:4/11/2017)... Florida , April 11, 2017 ... a security technology company, announces the appointment of independent Directors ... Bendheim to its Board of Directors, furthering the company,s ... ... of NXT-ID, we look forward to their guidance and benefiting ...
(Date:4/5/2017)... April 5, 2017  The Allen Institute for Cell ... Explorer: a one-of-a-kind portal and dynamic digital window into ... data, the first application of deep learning to create ... cell lines and a growing suite of powerful tools. ... these and future publicly available resources created and shared ...
(Date:4/5/2017)... -- KEY FINDINGS The global market for ... of 25.76% during the forecast period of 2017-2025. The ... the growth of the stem cell market. ... INSIGHTS The global stem cell market is segmented on ... stem cell market of the product is segmented into ...
Breaking Biology News(10 mins):